• linkedin
  • Increase Font
  • Sharebar

    How kidney Ca management strategies compare

     

    Intravenous osmitrol (Mannitol) infusion during nephron-sparing surgery does not lead to clinically relevant improvement in renal function outcomes and should be discontinued.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll